Non-executive Director

Benjamin Hart

Appointed: 2025

Benjamin Hart brings 16 years of investment experience spanning public and private markets across a range of industries. As an Analyst at Ruane Cunniff LP since 2022, and previously a Portfolio Manager for Glenville Capital Management, Benjamin brings an understanding of business strategy, value creation, and capital markets. His experience includes direct investments in early-stage life science ventures, including those engaged in liquid biopsy development. With five years of prior board service as a Director for a technology startup, Benjamin contributes valuable perspectives on governance, capital allocation, and a strategic approach to commercial development. He holds a B.A. in Business Administration from Franklin & Marshall College and is a CFA Charterholder.

Discover how ANGLE can help with your liquid biopsy needs

Contact us

Request a meeting with






    CelLBxHealth Logo
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.